• 1. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 2. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 3. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 4. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 5. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Peptides
• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Peptides
• Other Chemical Reagents

Introduction to Glutathionesulfonic acid (CAS No. 3773-07-7)

Glutathionesulfonic acid, with the chemical formula C₅H₉NO₆S, is a compound that has garnered significant attention in the field of pharmaceutical and biochemical research due to its unique structural and functional properties. This compound, identified by its CAS number 3773-07-7, is a derivative of glutathione, a well-known tripeptide with immense biological significance. The introduction of a sulfonic acid group in Glutathionesulfonic acid imparts distinct chemical characteristics that make it a valuable intermediate in synthetic chemistry and a potential candidate for various therapeutic applications.

The molecular structure of Glutathionesulfonic acid features a glutathione backbone, which consists of glutamic acid, cysteine, and glycine residues. The addition of a sulfonic acid group at the terminal carboxyl group enhances the solubility and reactivity of the molecule, making it particularly useful in aqueous-based systems. This property is particularly advantageous in pharmaceutical formulations where solubility is a critical factor for drug delivery and bioavailability.

In recent years, Glutathionesulfonic acid has been explored for its potential role in modulating oxidative stress and inflammation. Glutathione itself is renowned as a major intracellular antioxidant, playing a pivotal role in protecting cells from oxidative damage caused by reactive oxygen species (ROS). The sulfonic acid derivative appears to retain these antioxidant properties while also offering additional functionalities due to the presence of the sulfonic acid moiety.

One of the most compelling areas of research involving Glutathionesulfonic acid is its application in drug development. The compound's ability to act as a precursor or intermediate in synthesizing more complex molecules has made it valuable in the production of novel therapeutic agents. For instance, researchers have investigated its use in generating derivatives that exhibit enhanced bioavailability or targeted delivery mechanisms. These advancements are particularly relevant in the context of oncology, where efficient drug delivery systems can significantly improve treatment outcomes.

Recent studies have also highlighted the potential of Glutathionesulfonic acid in managing neurological disorders. Oxidative stress and inflammation are key pathological features in conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. By leveraging the antioxidant and anti-inflammatory properties of Glutathionesulfonic acid, researchers aim to develop therapeutic strategies that can mitigate these pathological processes. Preliminary findings suggest that this compound may help protect neuronal cells from damage and promote neuroprotection.

The pharmacokinetic profile of Glutathionesulfonic acid is another area of active investigation. Due to its sulfonic acid group, the compound exhibits good water solubility, which facilitates its absorption and distribution throughout the body. This characteristic makes it an attractive candidate for intravenous or oral administration. Additionally, the compound's stability under various physiological conditions enhances its suitability for clinical applications.

In conclusion, Glutathionesulfonic acid (CAS No. 3773-07-7) represents a promising compound with diverse applications in pharmaceutical and biochemical research. Its unique structural features, combined with its biological activities, position it as a valuable tool for developing novel therapeutic agents. As research continues to uncover new insights into its mechanisms of action and potential benefits, Glutathionesulfonic acid is poised to play an increasingly significant role in addressing various health challenges.

• 80267-15-8(gamma-D-glutamyltaurine)
• 56488-60-9(Glutaurine)
• 64703-84-0(Cyclo(3-sulfo-D-alanyl-3-sulfo-D-alanyl-L-valyl-D-leucyl-L-isoleucyl)(9CI))
• 87047-22-1(Pentanoic acid, 4-(acetylamino)-5-oxo-5-[(2-sulfoethyl)amino]-, (S)-)
• 93981-26-1(Butanoic acid,2-[(1-oxododecyl)amino]-4-sulfo-, sodium salt (1:1))
• 82637-03-4(Butanoic acid, 3-(acetylamino)-4-oxo-4-[(2-sulfoethyl)amino]-, (S)-)
• 79560-92-2(Acetylcysteine Impurity 3)
• 94291-92-6(Butanoic acid,2-[(1-oxooctadecyl)amino]-4-sulfo-, sodium salt (1:1))
• 87047-24-3(Pentanoic acid, 4-amino-5-oxo-5-[(2-sulfoethyl)amino]-, (S)-)
• 391866-99-2(Glutamic acid, N-[3-[(1-oxooctadecyl)(2-sulfoethyl)amino]propyl]-)